CORAL SPRINGS, Florida, October 20, 2016 /PRNewswire/ — For the most part Biotech stocks in general have performed well over the past year or so and appear to be bouncing back from a slump that began in the later part of last year. Some biotechs and pharma companies to keep a close eye on include Teva…